January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 

February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure (HF) patients published in the

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent Rapiscan (Regadenoson).

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case you’d like to share with DAIC's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Share your unique cases with your peers! The Clinical Case of the Month will be updated regularly, and featured both online and in the digital edition of DAIC.

February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as that from other causes, the abnormalities are less severe and result in less functional impairment, suggests a study yesterday in Radiology.

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human.

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now